Metallo-β-Lactamases: Structure, Function, Epidemiology, Treatment Options, and the Development Pipeline.

Antimicrobial Agents and Chemotherapy
Sara E BoydWilliam W Hope

Abstract

Modern medicine is threatened by the global rise of antibiotic resistance, especially among Gram-negative bacteria. Metallo-β-lactamase (MBL) enzymes are a particular concern and are increasingly disseminated worldwide, though particularly in Asia. Many MBL producers have multiple further drug resistances, leaving few obvious treatment options. Nonetheless, and more encouragingly, MBLs may be less effective agents of carbapenem resistance in vivo, under zinc limitation, than in vitro Owing to their unique structure and function and their diversity, MBLs pose a particular challenge for drug development. They evade all recently licensed β-lactam-β-lactamase inhibitor combinations, although several stable agents and inhibitor combinations are at various stages in the development pipeline. These potential therapies, along with the epidemiology of producers and current treatment options, are the focus of this review.

References

Jan 1, 1991·Antimicrobial Agents and Chemotherapy·M WatanabeS Mitsuhashi
Jun 1, 1967·The Biochemical Journal·S Kuwabara, E P Abraham
Jun 24, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J H SalonenO Meurman
May 29, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Esin SenolDavid R Snydman
Jun 1, 1965·Helvetica Chimica Acta·A L HAENNIE LEDERER
Jan 16, 2004·Journal of Applied Microbiology·R J W LambertS P Denyer
Jun 25, 2004·Antimicrobial Agents and Chemotherapy·Gianpiero GarauOtto Dideberg
Apr 16, 2005·Clinical Microbiology Reviews·Timothy R WalshPatrice Nordmann
May 6, 2005·The Journal of Antimicrobial Chemotherapy·Barry G Hall, Miriam Barlow
Oct 8, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·T R Walsh
Jun 6, 2006·The Journal of Antimicrobial Chemotherapy·Alexandre Prehn ZavasckiLuciano Zubaran Goldani
Apr 25, 2007·Antimicrobial Agents and Chemotherapy·George L DaikosNikolaos Katsilambros
Feb 16, 2008·Science·Brian D CorbinEric P Skaar
Jun 14, 2008·Bioinorganic Chemistry and Applications·Michael I Page, Adriana Badarau
May 16, 2009·Urological Research·Hans-Göran TiseliusMari-Anne Nilsson
Jun 2, 2009·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·P GiakoupiUNKNOWN Greek System for the Surveillance of Antimicrobial Resistance
Dec 10, 2009·Antimicrobial Agents and Chemotherapy·Karen Bush, George A Jacoby
Aug 18, 2010·Antimicrobial Agents and Chemotherapy·Nobumasa AokiKeizo Yamaguchi
Oct 12, 2010·The Journal of Antimicrobial Chemotherapy·Laura VillaAlessandra Carattoli
Nov 3, 2010·Antimicrobial Agents and Chemotherapy·David M LivermoreNeil Woodford
Mar 5, 2011·The Lancet Infectious Diseases·David M LivermoreNeil Woodford
Oct 18, 2011·Emerging Infectious Diseases·Patrice NordmannLaurent Poirel
Nov 8, 2011·International Journal of Antimicrobial Agents·Malaika L LittleScott J Weissman
Dec 7, 2011·Antimicrobial Agents and Chemotherapy·Laurent PoirelPatrice Nordmann
Jan 11, 2012·Clinical Microbiology Reviews·Joanna S Brooke
Feb 1, 2012·Antimicrobial Agents and Chemotherapy·Lisandro J González, Alejandro J Vila
Apr 19, 2012·PloS One·Rémy A BonninPatrice Nordmann
Jul 4, 2012·Proceedings of the National Academy of Sciences of the United States of America·David E EhmannStewart L Fisher
Nov 21, 2012·Annals of the New York Academy of Sciences·Timothy Palzkill
Dec 13, 2012·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Ayumi YoshizumiKazuhiro Tateda
Jan 8, 2013·Diagnostic Microbiology and Infectious Disease·David van DuinRobert A Bonomo
Mar 8, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C M HasanC G Giske

❮ Previous
Next ❯

Citations

Nov 4, 2020·Future Microbiology·Matteo BassettiDaniele R Giacobbe
Dec 10, 2020·International Journal of Molecular Sciences·Juan C Vázquez-UchaAlejandro Beceiro
Feb 23, 2021·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Fatma Ben AbidAli S Omrani
Mar 9, 2021·Frontiers in Microbiology·Wentian LiuShangshang Qin
Apr 15, 2021·Expert Review of Clinical Pharmacology·Anselm Jorda, Markus Zeitlinger
May 28, 2021·Journal of Hepatology·Javier FernándezEmmanuel Q Wey
Jun 12, 2021·Bioorganic Chemistry·Laurent GavaraJean-François Hernandez
Jul 27, 2021·Antimicrobial Agents and Chemotherapy·Carolina LópezAlejandro J Vila
Aug 10, 2021·Antimicrobial Agents and Chemotherapy·Marie de BarsyPierre Bogaerts
Nov 9, 2021·Journal of Chemical Information and Modeling·Zongfan YangAdrian J Mulholland

❮ Previous
Next ❯

Related Concepts

Related Feeds

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Related Papers

Pakistan Journal of Pharmaceutical Sciences
Irsa MateenMuhammad Anjum Zia
Antimicrobial Agents and Chemotherapy
Jürgen BremChristopher J Schofield
© 2021 Meta ULC. All rights reserved